cirrhotic
cirrhotic
1. 18 Mccormic CK PA,Dick R,Siving OS.Octreotide reduce azygos blood flow in cirrhotic patients with portal hypertention.
17张素惠，周建芳.奥曲肽治疗老年人食管静脉曲张破裂出血临床分析.世界华人消化杂志1999;7：733
2. Pericardial devascularization plus endoscopic variceal ligation(EVL) was applied in our hospital as a new union devascularization therapy for 66 cirrhotic portal hypertension patients since 1993.
1993年以来,我院应用贲门周围血管离断术加内镜下曲张静脉套扎术治疗门静脉高压症66例。
3. 2 Utsunomiya T, Matsumata T. Metastatic carcinoma in the cirrhotic liver. Am J Surg 1993;166:776
1夏振龙.大肠癌肝转移的发生率及临床特点.中国实用外科杂志1999;19:579
4. 3 Terg R, Berreta J, Abecasis R, et al. Dextran administration avoids hemodynamie changes following paracentesis in cirrhotic patients.
2贡齐铁，姚希贤，姜慧卿.排放腹水、静脉输注白蛋白对肝硬变患者有效血容量、电解质和肾功能的影响.中华消化杂志，1995；15(3)：186
5. So it is recommended that DSCS be employed for the treatment of the lesions of gastric mucosa in case of cirrhotic portal hypertension.
DSCS术后选择性改善了胃底部的微循环及功能，对治疗粘膜病变有一定意义。
6. Effect of eNOS Gene Transfer on the Capacity of Hepatic Sinusoids in cirrhotic rats.
eNOS基因治疗对肝硬化大鼠肝窦容积的影响
7. The positive rate for both HBV (HBsAg and/or HBcAg) and HCV Ag was also increased in HCC group (14/39,35.89%) compared with cirrhotic group(9/48, 18.75%),but did not reach statistical significance.
HBV和HCV抗原同时阳性者在HCC组(14/39,35.89%)高于肝硬化组(9/48,18.7%),但其差别亦达不到统计学显著性.
8. Evaluateing prognosis of cirrhotic patients by MELD score combined with serum bilirubin
MELD评分联合血清胆红素水平预测肝硬化预后
9. Prognostic evaluation of non-alcoholic cirrhotic patients by means of MELD score combined with HDL-ch levels
MELD评分联合血清高密度脂蛋白胆固醇水平预测非酒精性肝硬化预后
10. The Clinical Observation of Cirrhotic Portal Hypertension TIPSS Treated and TIPSS with SEEV(Analysis of 84 caes)
TIPSS与TIPSS并用SEEV治疗肝硬变门静脉高压的临床观察（附84例报告）
11. Study on Application of TIPSS in the Treatment of Cirrhotic Portal Hypertension
TIPSS治疗肝硬化门脉高压的应用研究
12. Chu YK, Ma QJ, Liu W, et al.Pathomorphological change in gastric mucosa after liver ischemia reperfusion in cirrhotic rats [J].J Hepatobil Surg, 2003, 11(1): 70-1.
[11]褚延魅,马庆久,刘维,等.肝硬化鼠肝缺血再灌注胃粘膜病理损伤的研究[J].肝胆外科杂志,2003,11(1):70-1.
13. CAO ZX, CHEN XP, WU ZD.The changes of immune function af ter hepatectomy for hepatocellular carcinoma in cirrhotic patients[J].Chin J Gen Surg, 2002, 17(6): 328-9.
[6]曹志新,陈孝平,吴在德.肝细胞癌合并肝硬化患者肝切除联合脾切除的临床意义探讨[J].中华普通外科杂志,2002,17(6):328-9.
14. cirrhotic liver
[医] 硬变肝
15. cirrhotic kidney
[医] 硬变肾, 固缩肾, [颗]粒状肾
16. biliary cirrhotic liver
[医] 胆汁性肝硬变
17. cirrhotic tuberculosis
[医] 闭锁性肺结核, 非开放性肺结核
18. Effects of Nitric Oxide, Interleukin 2 and Interleukin 8 on Portal Hemodynamics of Cirrhotic Patients
一氧化氮与白介素2、8对肝硬化门脉系统血流量的影响
19. Expression of nitric oxide synthase in human hepatocellular carcinoma and cirrhotic liver tissue and its clinical significance.
一氧化氮合酶在原发性肝癌及癌旁肝硬化组织中的表达及其意义。
20. The effects of disconnection and shunt procedure on hepatic hemodynamics and function of active cirrhotic patients with portal hypertension
不同术式对活动性肝硬化门静脉高压症患者肝脏血流动力学和肝功能的影响
21. This lesion should be suspected whenever a cirrhotic patient exhibits unexplained clinical deterioration.
不论何时,凡肝硬变患者一旦出现原因不明的衰弱,都应怀疑肝癌.
22. To Test the value of therapeutic paracentesis, peritoneal lavage and abdominal antibiotic administration in cirrhotic patients with spontaneous bacterial peritonitis(SBP).
为探讨腹腔穿刺放液,灌洗及注射抗生素对肝硬化合并自发性细菌性腹膜炎(SBP)的治疗价值。
23. He illustrated his point with a slide of a cross-sectional sample from a cirrhotic liver on which he overlaid biopsy needle placement.
他用一组硬化患者肝穿的横断面样本幻灯解释示意。
24. As a result, "a patient may be told at one point that he or she has mild disease, only to find out a year later that the liver is cirrhotic," he said.
他用一组硬化患者肝穿的横断面样本幻灯解释示意。针头可以穿在一个位置但是错过旁边的硬化组织，但是只要将针头移动几个毫米就检查到深度硬化的组织。
25. In this study the appropriate values of sensitivity, specificity and effectiveness of TSA in effusions for cancer and cirrhotic obtained were 88%,90.47% and 89.13% respectively.
以肝硬化组的 TSA+2SD 作为恶性组和肝硬化组的鉴别值,其敏感性为88%,特异性为90.47%,有效性为89.13%。 LSA 则无鉴别价值。
26. Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats.
促红细胞生成素与一氧化氮合酶抑制剂对肝硬化大鼠高动力循环状态的影响。
27. The other component includes metachronous tumors that arise de novo in a preneoplastic cirrhotic liver.
其他成分，包括在肿瘤（发生）前的硬变肝内出现新形成的异时肿瘤。
28. The two other patients were cirrhotic, but had no further identifiable risk factors.
其它两个病人有肝硬化，但并未发现其他危险因素。
29. Study of the Average Grey Scale Values and Color Point Percentage in Normal and Cirrhotic Livers before and after Levovist Enhancement
利声显增强前后正常肝和肝硬化平均灰度值和彩点百分比研究
30. CLINICAL ANALYSIS ON TREATING 46 CASES OF CIRRHOTIC PORTAL HYPERTENTION WITH PROSTAGLANDIN E 1
前列腺素E_1治疗肝硬化门静脉高压症46例
31. Keywords Bie Jia Jian;Cirrhotic;Liver fibrosis;Bilirubin;Hemoglutination function;
加减鳖甲煎;肝硬化;肝纤四项;胆红素;凝血功能;
32. Effects of Glypressin on Gastric Mucosal Blood Flow and Vaso-active Substances in Cirrhotic Rats
可利新对肝硬化大鼠胃粘膜血流量及血管活性物质的影响
33. The changes of plasma renin activity in cirrhotic patients with ascites undergoing portacaval shunt
合并腹水的门静脉高压症患者门腔静脉分流术前后血中肾素活性的变化
34. In conclusion, congestive gastropathy is a common finding in cirrhotic patients.Its appearance is closely correlated with the severity of liver disease.
因此我们的结论是：（1）郁性胃病变常见于肝硬病人且和肝病严重程度有关。
35. At the time of enrolment, HCC was diagnosed in 20 cirrhotic patients.
在入选登记时，有20例肝硬化患者被诊断出患有肝细胞癌证。
36. Portacaval shunts have been performed for recent variceal hemorrhage in cirrhotic patients without the physician suspecting that a hepatoma was responsible for the portal hypertension.
在肝硬化患者的门静脉与腔静脉的吻合分流处新近出现的静脉曲张出血症状，医师却没有怀疑到这是肝细胞瘤引起血压过度紧张造成的。
37. The efficacy and safety of a branched-chain amino acids granules in the treatment of cirrhotic hypoproteinemia--A multicenter, randomised, control study
复方支链氨基酸颗粒剂治疗肝硬化低蛋白血症多中心临床观察
38. Utsunomiya T,Matsumata T.Metastatic carcinoma in the cirrhotic liver.Am J Surg 1993;166:776
夏振龙.大肠癌肝转移的发生率及临床特点.中国实用外科杂志1999;19:579
39. Diagnostic value of multi-slice CT angiography in different collateral pathways: pancreatic versus cirrhotic portal hypertension
多层螺旋CT血管成像诊断胰源性与肝硬化门脉高压不同侧支循环的价值
40. Keywords Rat Cirrhotic liver Magnetic resonance imaging Magnetization transfer contrast;
大鼠;肝硬化;磁共振成像;磁化传递对比;
41. Reduced expression and dynamic alteration of growth hormone receptors in cirrhotic hepatocytes of rats
实验性肝硬化肝细胞生长激素受体的表达与动态变化
42. For cirrhotic patients, perhaps you can't stop treatment.
对肝硬化的患者，可能不能停止治疗。
43. Many of the known risk factors for postmenopausal osteoporosis exist in the cirrhotic population, such as excess alcohol intake, steroid use, poor nutrition, and hypogonadism.
尤其那些血色沉著病和胆道疾病患者虽无肝硬化但骨质疏松风险可能会更高。
44. Effect of helicobacter pylori infection on hyperdynamic circulatory state and portal hypertensive gastrropathy in liver cirrhotic patients
幽门螺杆菌感染在肝硬化、肝癌高动力循环及胃黏膜病变中的作用
45. Experimental study of applying recombinant human growth hormone to treat cirrhotic rats with ascites
应用重组人生长激素治疗肝硬化腹水大鼠的实验研究
46. Influence of Radix Angelicae Sinensis on splanchnic plasma TXA_2 and PGI_2 levels in cirrhotic dog
当归对胆管结扎肝硬化犬血浆TXA_2/PGI_2水平的影响
47. Color doppler study of fasting and postprandial hemodynamic changes in hepatic artery and portal vein in cirrhotic patients
彩色多普勒对肝硬化患者入肝血管的血流动力学研究
48. Patients and methods: Sixty-six patients with fibrotic to cirrhotic hepatitis C virus-related CLD， were consecutively included upon referral to our haemodynamic laboratory.
患者和方法： 推荐到我们的血液动力学实验室的连续的66名CLD患者进入了本研究，他们是丙肝病毒相关的肝纤维化或肝硬化的患者。
49. Abstract Objective To evaluate the role of nitric oxide(NO) in hyperdynamic circulation in cirrhotic portal hypertension.
摘 要 目的 探讨NO在肝硬变门脉高压血流动力学中的作用。
50. Abstract AIM: To established a rats cirrhotic model by a small dose of endotoxin injection peritoneally and clarify its possible pathogenesis.
摘 要 目的： 观察外源性内毒素诱发肝硬化大鼠发生肝性脑病的可能性及可能机制。
51. Abstract： Objective：To observe the protective function of arginine to liver in the cirrhotic rats administrated by TPN.
摘 要： 目的:观察精氨酸对肝硬化大鼠全胃肠外营养时的肝保护作用。
52. Abstract ABSTRACT:Objective To research on the main pattern of hepatic cells death during hepatic ischemia/reperfusion(I/R) injury in cirrhotic rat.
摘要 摘要：目的 研究肝硬化大鼠肝缺血再灌注(I/R)损伤时肝细胞死亡的主要方式。
53. Objective To analyze the cause of in-hospital death from variceal bleeding in cirrhotic patients with portal hypertension.
摘要目的探讨肝硬化门静脉高压症食管胃底曲张静脉破裂出血患者住院期间的死亡原因。
54. Objective: To evaluate the efficacy of endoscopic variceal ligation (EVL) combined with partial splenic embolization (PSE) in the treatment of cirrhotic patients with portal hypertension.
摘要目的：探讨内镜静脉套扎(EVL)和部分性脾栓塞(PSE)联合治疗肝硬化门脉高压症的效果。
55. Portal-azygous devascularization can maintain PVP and PG in portal vein and do not affect liver function of the control rats but it can damage liver cell in cirrhotic rats.
断流术能维持PVP及门脉血PG水平，对正常大鼠肝功能影响小，但对肝硬变大鼠的肝细胞有损害。
56. Methods Retrospectively analysis were ultrasound findings in 8 patients of Budd-Chiari syndrome and 30 patients of cirrhotic portal hypertension.
方法 回顾性分析8例布加综合征和30例门脉性肝硬化患者的超声影像资料。
57. Methods A control study was performed to compare two cirrhotic groups:25 cases with gallstone(gallstone group),30 cases without gallstone(control group).
方法:采用病例对照研究法,25例肝硬化合并胆石症患者为胆石组,30例肝硬化无胆石症患者为对照组。
58. Materials and Methods: Ten cirrhotic patients (group A) underwent minor liver resections due to hepatocellular carcinoma (HCC).
方法和材料：10个肝硬化患者（A组）因为肝细胞癌行肝次全切。
59. Methods Seasonal changes of 524 times of upper digestive tract hemorrhage occurring in 370 cases of cirrhotic portal hypertension were retrospectively analyzed.
方法对370例肝炎肝硬化门脉高压患者发生的524例次上消化道出血的四季分布进行了回顾性调查。
60. Methods The esophageal varices of 45 cases with cirrhotic patients were treated by endoscopic sclerotherapy with non-water ethanol totalling 96 times.
方法对我院45例肝硬化并发食管静脉曲张的患者,在内镜下用无水酒精行96次静脉内注射。
61. Methods The clinical data of variceal bleeding in cirrhotic patients with portal hypertension admitted in recent three years to our hospital were analyzed retrospectively.
方法对近3年收治的186例患者及在住院期内死亡的24例患者的临床资料进行回顾性分析。
62. Methods Investigate the relationship of the electrolyte's turbulences and ascites levels and hepatic encephalopathy by statistical analysis of 121 cases of cirrhotic Ascites.
方法本文分析总结了肝硬化腹水病人121例，通过统计学处理了解电解质紊乱与腹水程度、肝性脑病的关系。
63. Method 90 Cirrhotic patients with HE were randomly divided into two groups.
方法肝硬化合并肝性脑病90例,随机分成治疗组和对照组。
64. Methods There were 52 patients including 26 with primary hepatocellular carcinoma and 26 with liver cirrhotic nodules.
方法选取52例患者，其中原发性肝细胞癌26例，肝硬化结节26例。
65. Method 80 cirrhotic patients accepted gastric endoscpy and CT examine,measure the diameter of esophageal varices in the esophageal lumina of CT image.
方法选择80位肝硬化患者,所有患者均接受胃镜及食道CT检查,测量CT图像下食管腔内曲张食道静脉直径。
66. Methods We used a radioimmunoassy to determine serum leptin concentrations in 43 cirrhotic patients with normal renal function and 30 controls matched for gender, age and body mass index(BMI).
方法选择肾功能正常的43例肝硬化患者和30例与其在性别、年龄和体重指数(BMI)相匹配的对照者，应用放免法测定血清瘦素。
67. Methods: Between 1997 and 2006, we selected 45 cirrhotic patients with hepatocellular carcinoma distributed into two groups according to explant histology: MC and Expanded Milan Criteria (EMC).
方法： 1997年至2006年间，我们选定了45名肝硬化肝癌患者，并根据外植体组织学将其分成两组：MC组和扩大米兰标准（EMC）组。
68. Methods: The clinical data, the results of bacterial culture and drug sensitivity tests of 108 ascitic specimens from cirrhotic patients with SBP were analyzed retrospectively.
方法：对108例次腹水细菌培养阳性肝硬化腹水合并SBP患者的临床资料以及腹水细菌培养和药物敏感试验结果进行回顾性分析。
69. Methods: A total of 50 cirrhotic patients who underwent both endoscopy and multislice spiral CT within a 4-week interval were prospectively evaluated.
方法：纳入肝硬化患者50例，在4周内分别行内镜和多层螺旋CT检查。
70. Early detection of neuropsychological dysfunction in cirrhotic patients without overt encephalopathy is essential to their prognosis and quality of life.
早期探测肝硬化患者神经精神障碍对于患者的预后及提高生活质量是很重要的。
71. Effects of preoperative ultraviolet blood irradiation oxygen therapy on cirrhotic patients with hepatocirrhosis portal hypertension
术前光量子血氧疗法对肝硬化门静脉高压症的影响
72. At the time of first postoperative week, the mean blood glucose value in the 120-minute OGTT in each PAD, PCS and DSCS groups had significant differences compared with the cirrhotic control group (P < 0.05).
术后第1周DSCS、PAD、PCS组OGTT 120 min血糖值分别为(12.2±2.6)、(12.4±2.8)和(12.6±2.7)mmol/L比肝硬化对照组(9.0±2.4)mmol/L有显著升高;
73. Materials and methods67 cases of patients with cirrhotic ascites,39 cases with carcinous ascites, 14 cases with tuberculosic ascites were examized ultrasonograhically.
材料与方法通过对肝硬化腹水67例，癌性腹水39例，结核性腹水14例进行观察，分析不同原因腹水患者的胆囊、肠管、腹水及腹膜的变化。
74. Materials and Methods: Percutanous splenic artery DSA was performed in 20 patients with cirrhotic portal hypertension befor operation and 2 years after operation repeetively.
材料与方法：对20例患者于术前、术后2年分别行脾动脉DSA检查。
75. Materials and Methods:Cirrhotic patients needed for interventional therapy were assigned into group D (DIPS) and group T (TIPS) randomly.
材料和方法:随机将需行介入治疗的肝硬化门脉高压患者分入DIPS(D组)及TIPS(T组)。
76. It is also arising in a cirrhotic (nodular) liver.
此病变也可由肝硬化发展而来。
77. Prof.McCullough: Every cirrhotic patient has a loss in protein even if it is undetectable by standard methods clinically.
每位肝硬化患者都存在蛋白质过多的损耗，有时甚至使用标准临床方法也检测不出来。
78. Endothelium-dependent Relaxation Effect of Rhizoma Al ismatis in Aortic Rings of Liver Cirrhotic Rats
泽泻对肝硬变大鼠主动脉的扩血管作用及机制
79. Effect of somatostatin on portal and hepatic hemodynamics and portal venous pressure in cirrhotic patients with portal hypertension
生长抑素对肝硬变门静脉高压症患者门静脉、肝静脉血流和门静脉压力的影响
80. Expression of Growth Hormone Receptor mRNA in Hepatocellular Carcinoma and Matched Para- Cancer Cirrhotic Liver Tissue
生长激素受体mRNA在肝细胞癌和癌旁肝硬化组织中的表达
